RECURRENT BURKITT LYMPHOMA
Clinical trials for RECURRENT BURKITT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BURKITT LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT BURKITT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to beat back tough blood cancers
Disease control Recruiting nowThis study is for people whose acute lymphoblastic leukemia, lymphoblastic lymphoma, or related blood cancers have returned or stopped responding to treatment. Researchers are testing a combination of six chemotherapy drugs to see if it can shrink tumors and control the disease. …
Matched conditions: RECURRENT BURKITT LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:44 UTC
-
New combo therapy aims to tackle tough leukemia
Disease control Recruiting nowThis study tests a drug called inotuzumab ozogamicin, which targets and kills leukemia cells, combined with low-intensity chemotherapy. It is for adults with acute lymphoblastic leukemia (ALL), including those who are older or whose cancer has returned. The goal is to find the be…
Matched conditions: RECURRENT BURKITT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:08 UTC